Rameen Beroukhim, MD, PhD
Year elected: 2017
Current membership category: Active
Dana-Farber Cancer Institute
450 Brookline Ave
DA 1536
Boston, MA 02215
United States of America
Phone: 617-582-7941
Email: rameen_beroukhim@dfci.harvard.edu

Biographical statement

Our research focuses on understanding the somatic genetic changes that occur in cancer, and what these genetic changes can tell us about how different cancers will behave.

We have undertaken a variety of genomic approaches to profiling large numbers of cancers, including the use of SNP arrays, expression arrays, and sequencing, and have developed several computational approaches to understand these data.

For copy-number changes, which are some of the most frequent somatic genetic events in cancer, we developed an approach (GISTIC, for Genomic Identification of Significant Targets In Cancer) that simultaneously identifies those events that are most likely to drive cancer development and profiles individual specimens for the set of events they have undergone.

We have used this approach to identify new oncogenes in several cancer types, including lung, esophageal, and colorectal cancers. We have also applied it across thousands of cancer copy-number profiles from multiple histologic types, enabling us to determine that most copy-number changes are not unique to individual cancer types, but shared across multiple cancer types.

We have also used this approach, coupled with additional genomic information, to identify prognostic indicators in endometrial cancers and predictors of pathway dependency several cancer types, including glioblastoma and renal cancer.

Institutional affiliations

Harvard Medical School, Dana-Farber Cancer Institute (Primary)
William C. Hahn, MD, PhD is the representative at this institution.


Medical Oncology